Mitochon Pharmaceuticals Revenue

Biotechnology Research • Blue Bell, Pennsylvania, United States • 1-10 Employees

Mitochon Pharmaceuticals revenue & valuation

Annual revenue	$10,000,000
Revenue per employee	$2,500,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$32,000,000
Total funding	$1,600,000

Key Contact at Mitochon Pharmaceuticals

John Geisler

Founder & CSO

Company overview

Headquarters	970 Cross Ln, Blue Bell, Pennsylvania 19422, US
Phone number	+12153133905
Website	mitochonpharma.com
SIC	283
Keywords	ALS, Alzheimer'S, Anti-Aging, Traumatic Brain Injury (Tbi), Military Medicine, Movement Disorders, Huntington'S Disease, Parkinson Disease, Multiple Sclerosis (Ms), Mitochondrial Medicine, Brain Derived Neurotrophic Factor (Bdnf), Enhanced Cognition
Founded	2014
Employees	1-10
Socials

Mitochon Pharmaceuticals Email Formats

Mitochon Pharmaceuticals uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@mitochonpharma.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@mitochonpharma.com	100%

About Mitochon Pharmaceuticals

Mitochon Pharmaceuticals is a clinically staged biotech that is focused on developing drugs that target the mitochondria for a host of serious diseases with significant unmet medical needs. Our development programs are primarily focused on neurodegenerative diseases including: Huntington’s Disease, Multiple Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s, Parkinson and Traumatic Brain Injury (TBI). Despite that these indications may appear different, on-going research suggests in fact a common link that all are rooted in mitochondrial dysfunction associated with overt free radical production, lower ATP production, calcium overload and slow turnover associated with aging. By correcting mitochondrial physiology, we aim at opening the way for a broad range of disease modifying therapies. Our platform is based upon mitochondrial enhancers that specifically target the mitochondria as an oral once-per-day brain penetrating therapy that wakes up compensatory pathways pro-survival (MOA: https://www.mitochonpharma.com/mechanism-of-action/). Mitochon is led by a team of industry executives with over 80-years of combined experience and a passion to bring forward breakthrough drug therapies for a host of devastating diseases.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Mitochon Pharmaceuticals has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Mitochon Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2016-06-17	1	$1,600,000

Funding Insights

$1,600,000

Total funding amount

$1,600,000

Most recent funding amount

Number of funding rounds

Mitochon Pharmaceuticals Tech Stack

Discover the technologies and tools that power Mitochon Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

AOS

JavaScript libraries

reCAPTCHA

Security

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

CivicTheme

UI frameworks

Nginx

Reverse proxies

PHP

Programming languages

Open Graph

Miscellaneous

Vimeo

Video players

WordPress

Blogs

WPForms

Form builders

Oxygen

Page builders

Frequently asked questions

Mitochon Pharmaceuticals is located in Blue Bell, Pennsylvania, US.

You can reach Mitochon Pharmaceuticals at +12153133905.

Mitochon Pharmaceuticals generates an estimated annual revenue of $10,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Mitochon Pharmaceuticals has an estimated valuation of $32,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Mitochon Pharmaceuticals was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

Mitochon Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Mitochon Pharmaceuticals has raised a total of $1,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Mitochon Pharmaceuticals

John Geisler

Founder & CSO

4.8

40,000 users